NorthAvenue LLC’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$844 Hold
2
– – ﹤0.01% 207
2026
Q2
$725 Hold
2
– – ﹤0.01% 246
2026
Q1
$704 Hold
2
– – ﹤0.01% 209
2025
Q4
$655 Buy
+2
New +$634 ﹤0.01% 240

Other funds holding AMGN

NorthAvenue LLC's AMGN Position: Q3 2026 in Review

NorthAvenue LLC held its Amgen (AMGN) position steady in Q3 2026 at 2 shares worth $844. The position accounts for ﹤0.01% of the portfolio, ranked #207.

NorthAvenue LLC first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • NorthAvenue LLC held 2 shares of Amgen worth $844 as of Q3 2026.
  • NorthAvenue LLC left its Amgen share count unchanged in Q3 2026.
  • Amgen made up ﹤0.01% of NorthAvenue LLC's portfolio in Q3 2026, its #207 holding.
  • NorthAvenue LLC first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on NorthAvenue LLC's 13F filing for Q3 2026, filed 29 Oct 2026.